Ignite Creation Date:
2025-12-24 @ 1:04 PM
Ignite Modification Date:
2026-01-29 @ 6:48 AM
Study NCT ID:
NCT00237861
Status:
COMPLETED
Last Update Posted:
2014-06-06
First Post:
2005-10-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia
Sponsor:
Yale University
Organization:
Study Overview
Official Title:
Effectiveness of Atypical Vs Conventional Antipsychotics
Status:
COMPLETED
Status Verified Date:
2014-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will compare the effectiveness of newer atypical antipsychotics versus older conventional antipsychotics in treating schizophrenia.
Detailed Description:
At seven participating hospitals, acutely exacerbated patients with schizophrenia were randomly assigned to treatment with antipsychotic from the atypical class vs antipsychotic from the conventional class. Medication choice within class, dose, concomitant medications, and other prescribing decisions were left to the community prescriber. Patients were followed for one year after discharge.
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| R01MH057292 | NIH | None | https://reporter.nih.gov/quic… | View |